HM Brokmeier, TG Seelhammer, SD Nei… - … of Cardiothoracic and …, 2023 - Elsevier
Hydroxocobalamin inhibits nitric oxide-mediated vasodilation, and has been used in settings of refractory shock. However, its effectiveness and role in treating hypotension remain …
SR Velamuri, Y Ali, J Lanfranco… - Clinics in Plastic …, 2024 - plasticsurgery.theclinics.com
The management of a large burn can prove to be extremely challenging. When this is compounded by the presence of smoke inhalation, the care gets even more complex with a …
DA Khandekar, TG Seelhammer, KC Mara… - … of Cardiothoracic and …, 2023 - Elsevier
Objectives Hydroxocobalamin inhibits nitric oxide pathways contributing to vasoplegic shock in patients undergoing cardiopulmonary bypass (CPB). The objective of this study was to …
C Wedemire, H Samavat, M Newkirk… - Nutrition in Clinical …, 2024 - Wiley Online Library
High‐dose vitamin B12 is a potential treatment for patients with vasodilatory shock that is refractory to other therapies. Vasodilatory shock is characterized by low blood pressure and …
Introduction Septic and vasoplegic shock are common types of vasodilatory shock (VS) with high mortality. After fluid resuscitation and the use of catecholamine-mediated vasopressors …
L Chiscano-Camón, JC Ruiz-Rodriguez… - Annual Update in …, 2023 - Springer
All patients with septic shock should be given the fundamental pillars of sepsis management (source control, antibiotic stewardship, initial hemodynamic resuscitation, and multi-organ …
M Blaha, M Blais, L Olson - Cureus, 2023 - ncbi.nlm.nih.gov
Objectives Refractory distributive shock (vasoplegia) has been treated with intravenous (IV) hydroxocobalamin (B12), but its use is poorly characterized. The objective of this study was …
We eagerly read the results by Patel et al 1 in this issue of CHEST regarding the vasopressor-sparing effects of a single high dose (5 g IV) of vitamin B12 (hydroxocobalamin …